Press Releases
View all press releases »
Lancet Gastroenterology and Hepatology: innovative antisense therapy shows potential to be safe and efficacious for the treatment of NAFLD and NASH
Lancet Gastroenterology and Hepatology: innovative antisense therapy shows potential to be safe and efficacious for the treatment of NAFLD and NASH
June 17, 2020 at 7:45 PM EDT
IONIS-InBrief-17June2020.pdf 516.4 KB